Clinical data management

RealTime Software Solutions Strengthens its Position in the Clinical Research Industry with the Acquisition of Devana Solutions

Retrieved on: 
Thursday, July 6, 2023
Software as a service, Clinical data management, Workflow, Clinical trial, CTMS, Acquisition, ESourcing Capability Model, SAN, PROPEL, RealTime, Payment, Medical imaging, Online shopping, Devana

SAN ANTONIO, July 6, 2023 /PRNewswire/ -- RealTime Software Solutions, LLC, a leading provider of cloud-based software solutions for the clinical research industry, is excited to announce its acquisition of Devana Solutions, LLC, an innovative SaaS provider specializing in clinical trial workflow and analytics solutions.

Key Points: 
  • SAN ANTONIO, July 6, 2023 /PRNewswire/ -- RealTime Software Solutions, LLC, a leading provider of cloud-based software solutions for the clinical research industry, is excited to announce its acquisition of Devana Solutions, LLC, an innovative SaaS provider specializing in clinical trial workflow and analytics solutions.
  • "Devana's platform perfectly complements our already robust suite of clinical trial software solutions," said Stephen Johnson, CEO of RealTime.
  • With this acquisition, RealTime Software Solutions reinforces its commitment to delivering innovative solutions that empower the clinical research industry and further streamline the development of life-changing treatments.
  • The combined expertise and capabilities of RealTime and Devana will propel the industry forward and set a new standard for end-to-end site platforms.

UNIVERSITY OF PITTSBURGH CTSI PARTNERS WITH THREAD TO ACCELERATE IMPACT OF TRANSLATIONAL RESEARCH

Retrieved on: 
Tuesday, June 27, 2023
Monash University Faculty of Medicine, Nursing and Health Sciences, School, Partnership, Data collection, University, Clinical data management, Research, American Opportunity Tax Credit, History, Outline of health sciences, Pharmaceutical industry, Thread

CARY, N.C., June 27, 2023 /PRNewswire/ -- Thread, a leading decentralized research, electronic clinical outcome assessment (eCOA) and consulting services provider, announced today that the University of Pittsburgh Clinical and Translational Science Institute (Pitt CTSI) selected it to accelerate the impact of translational research.

Key Points: 
  • CARY, N.C., June 27, 2023 /PRNewswire/ -- Thread, a leading decentralized research, electronic clinical outcome assessment (eCOA) and consulting services provider, announced today that the University of Pittsburgh Clinical and Translational Science Institute (Pitt CTSI) selected it to accelerate the impact of translational research.
  • The three-year partnership will support Pitt CTSI by making the clinical and translational research studies they support more accessible to communities, broadening the impact of discoveries across diverse populations.
  • "Pitt CTSI drives discovery by developing innovative programs and creating the infrastructure to support, disseminate, and implement translational research," said Dr. Steven Reis, director, Pitt CTSI.
  • "Pitt CTSI and Thread share a commitment to advancing scientific research for everyone, everywhere via a more inclusive, participant-focused approach," said Thread co-founder and CEO John Reites.

ClinChoice Partners with Anju to Simplify the Complexities of Life Science Information Management

Retrieved on: 
Monday, June 26, 2023
Partnership, Clinical data management, Clinical trial, Organization, SAE, Acquisition, Collection

FT. LAUDERDALE, Fla., June 26, 2023 /PRNewswire/ -- Anju Software, a leading life science technologies provider, announced that ClinChoice is expanding its footprint with TrialMaster and Anju's eClinical Suite.

Key Points: 
  • FT. LAUDERDALE, Fla., June 26, 2023 /PRNewswire/ -- Anju Software, a leading life science technologies provider, announced that ClinChoice is expanding its footprint with TrialMaster and Anju's eClinical Suite.
  • The partnership allows ClinChoice to deliver a full suite of cost-efficient and adaptable eClinical solutions providing impactful insights and accelerated results.
  • "With our acquisition of Cromsource, we welcomed Anju as a partner for eClinical solutions," stated Tiepu Liu, Clinchoice President of Global Biometrics.
  • "We look forward to supporting ClinChoice as they increase their global presence," stated Michael Loftus, Anju Vice President of CRO Partner Program.

ATCOR Medical Enters into Partnership Agreement with Datacubed Health to Increase Patient Retention and Engagement in Decentralized Clinical Trials

Retrieved on: 
Monday, June 26, 2023
Acceleration, Partnership, Clinical data management, Clinical trial, Biomarker, Pulse, Patient, FDA, Pharmaceutical industry, Medical imaging

IRVINE, Calif., June 26, 2023 /PRNewswire/ -- ATCOR Medical, subsidiary of CardieX and developer of innovative medical devices and digital solutions to personalize healthcare and improve clinical trial patient outcomes, today announces it has entered into a partnership agreement with Datacubed Health, a leading eClinical technology company, advancing access to healthcare for everyone, everywhere.

Key Points: 
  • The new partnership will allow ATCOR and Datacubed Health to jointly conduct trial monitoring across therapeutic programs, unveiling a unique patient-centric trial model designed to enhance the patient experience.
  • This partnership elevates the trial experience with a patient-centric trial model that personalizes the patient journey and advances patient access across therapeutic areas.
  • By integrating the Pulse with the Datacubed Health Platform, patients and clinicians now have several pathways to keep open communication channels to monitor patient health and maintain patient engagement to improve trial retention.
  • Together we are truly personalizing decentralized trials," stated Kimberly Tully, Managing Director, Clinical Trials Partnerships - ATCOR Medical.

Axiom Highlighting Fusion eClinical Suite at DIA 2023

Retrieved on: 
Friday, June 23, 2023
Clinical data management, Safety, Xiaogang Ma, Booth, Research, Metric, Suite, Safety data sheet, Axiom, DIA, Unified, EDC, Pharmaceutical industry

Axiom’s proprietary Fusion eClinical Suite enables effective collaboration and accelerated decision-making through real-time actionable data.

Key Points: 
  • Axiom’s proprietary Fusion eClinical Suite enables effective collaboration and accelerated decision-making through real-time actionable data.
  • “Axiom is thrilled to be back at the DIA Annual Meeting, highlighting Fusion eClinical Suite, the pre-eminent and global Unified eClinical platform.
  • Fusion eClinical Suite can help deliver eClinical and study operations needs.
  • To register for this event, please visit: https://www.diaglobal.org/en/flagship/dia-2023
    Learn more about Axiom’s Fusion eClinical Suite: https://www.axiommetrics.com/fusion-eclinical-suite/

Vial Announces Strategic Partnership with Royale International Group

Retrieved on: 
Thursday, June 22, 2023
Partnership, Clinical data management, Digital technology, Patient, ESourcing Capability Model, SAN, Royal International Air Tattoo, EDC, Vaccine, Warehouse, Vial, Royale

SAN FRANCISCO, June 21, 2023 /PRNewswire/ -- Vial , a global tech-driven CRO providing next-generation clinical trial management services, has partnered with the Royale International Group , one of the largest independent logistics providers in the Asia Pacific region.

Key Points: 
  • SAN FRANCISCO, June 21, 2023 /PRNewswire/ -- Vial , a global tech-driven CRO providing next-generation clinical trial management services, has partnered with the Royale International Group , one of the largest independent logistics providers in the Asia Pacific region.
  • Royale will provide Vial with temperature-controlled logistics solutions for clinical trials.
  • Royale International offers a comprehensive range of services that caters to diverse customer needs on a global scale.
  • We are excited to contribute to Vial CRO's mission of accelerating clinical trials for sponsors and patients worldwide," said Philip Murton, Sales Director for Royale.

Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster

Retrieved on: 
Tuesday, June 20, 2023
Central nervous system, CAB, Clinical data management, American Opportunity Tax Credit, Culture, Public, Biotechnology, Neurodegenerative disease, New York Medical College, Element, IRT, CNS, Science, Biometrics, Patient, Novo Nordisk, IDH1, Knowledge, Shirin David, Cardiology, Therapy, Psychiatry, Neurology, Pharmaceutical industry, Nursing

PHILADELPHIA, June 20, 2023 /PRNewswire/ -- Suvoda LLC , a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has tapped Irena Lerentracht Webster to join its board of directors.

Key Points: 
  • PHILADELPHIA, June 20, 2023 /PRNewswire/ -- Suvoda LLC , a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has tapped Irena Lerentracht Webster to join its board of directors.
  • Webster is a seasoned global drug development leader with over two decades of experience at sponsor, CRO, and site levels.
  • She has led global clinical trial strategy and execution in a myriad of therapeutic areas including neurology, psychiatry, oncology, cardiology, and rare disease, contributing to multiple NDAs and sNDAs.
  • In addition to joining the board of directors, Webster also serves on the Suvoda customer advisory board (CAB).

Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster

Retrieved on: 
Tuesday, June 20, 2023
Central nervous system, CAB, Clinical data management, American Opportunity Tax Credit, Culture, Public, Biotechnology, Neurodegenerative disease, New York Medical College, Element, IRT, CNS, Science, Biometrics, Patient, Novo Nordisk, IDH1, Knowledge, Shirin David, Cardiology, Therapy, Psychiatry, Neurology, Pharmaceutical industry, Nursing

PHILADELPHIA, June 20, 2023 /PRNewswire/ -- Suvoda LLC , a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has tapped Irena Lerentracht Webster to join its board of directors.

Key Points: 
  • PHILADELPHIA, June 20, 2023 /PRNewswire/ -- Suvoda LLC , a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has tapped Irena Lerentracht Webster to join its board of directors.
  • Webster is a seasoned global drug development leader with over two decades of experience at sponsor, CRO, and site levels.
  • She has led global clinical trial strategy and execution in a myriad of therapeutic areas including neurology, psychiatry, oncology, cardiology, and rare disease, contributing to multiple NDAs and sNDAs.
  • In addition to joining the board of directors, Webster also serves on the Suvoda customer advisory board (CAB).

Revolutionary Machine Learning Tool Transforms Clinical Trial Medical Coding

Retrieved on: 
Thursday, June 15, 2023
Data Management, Health, Technology, Health Technology, Software, Clinical Trials, Artificial Intelligence, Electronic data capture, Data management, Clinical trial, Algorithm, Noise, Machine learning, SDC, Clinical data management, Medical device, Sales

Today, SDC is proud to announce key enhancements to our services with the development of an innovative machine learning tool that is set to revolutionize Medical Coding for clinical trials.

Key Points: 
  • Today, SDC is proud to announce key enhancements to our services with the development of an innovative machine learning tool that is set to revolutionize Medical Coding for clinical trials.
  • "Our machine learning tool represents a significant leap forward in clinical trial medical coding," said Todd Bonta, Vice President, Clinical Data Management.
  • One of the key advantages of this machine learning model is its ability to centralize medical coding across multiple platforms.
  • From an operational standpoint, the implementation of this machine learning tool streamlines the coding process, reducing manual effort and enhancing efficiency for the coding team.

Alcanza and Reveles Partner to Expand Inclusive Clinical Research in Underrepresented Communities

Retrieved on: 
Wednesday, June 14, 2023
Black and Brown!, Health equity, Clinical trial, Partnership, Clinical data management, Islam in the Dallas–Fort Worth metroplex, Education, Pharmaceutical industry, Management, Revel Systems

BOSTON, June 14, 2023 /PRNewswire/ -- Alcanza Clinical Research, mission-driven investigator site network, announced today a strategic partnership with Reveles, a provider of equity-driven decentralized clinical trials.

Key Points: 
  • BOSTON, June 14, 2023 /PRNewswire/ -- Alcanza Clinical Research, mission-driven investigator site network, announced today a strategic partnership with Reveles, a provider of equity-driven decentralized clinical trials.
  • Alcanza announces a partnership with Reveles to bring decentralized clinical trials to underrepresented communities.
  • Reveles provided successful decentralized clinical trial approaches for several recent studies with Alcanza, offering staff augmentation, remote data entry, and pre-screening support.
  • "We were thrilled to choose Reveles as our partner for recent work," said Carlos Orantes, CEO of Alcanza.